HDAC4 and gastric cancer: Importantly, and underlining the role of HDAC4 as resistance and pro-tumoral factor, is that when going deeper into the analysis of TCGA data on GC, Spaety and co-workers found that patients with a mutated HDAC4 have an overall better survival than patients with a wild type HDAC4 [57].